KẾT QUẢ ĐIỀU TRỊ NHIỄM HELICOBACTER PYLORI BẰNG PHÁC ĐỒ 4 THUỐC CÓ BISMUTH Ở BỆNH NHÂN VIÊM, LOÉT DẠ DÀY - TÁ TRÀNG TẠI BỆNH VIỆN QUÂN DÂN Y TỈNH BẠC LIÊU

Abstract

Background: Helicobacter pylori (H. pylori) infection is one of the main causes of gastric and duodenal ulcers.The World Society of Gastroenterology (WGO) 2021 recommends that the 4-drug regimen containing bismuth is the first choice regimen for patients infected with Helibacter pylori who have never been treated or have failed previous treatment to eradicate Helicobacter pylori. Objectives: Describe clinical characteristics and endoscopic images in patients with Helicobacter pylori-positive gastric and duodenal ulcers and Evaluate the results of eradication treatment with a 4-drug regimen Bismuth. Subjects and method: The patient was diagnosed with duodenal ulcer, examined and treated at the Military and Civilian Hospital of Bac Lieu Province. Research design: descriptive cross-sectional study Results: Among 582 patients with duodenal ulcers infected with Helicobacter pylori, abdominal pain symptoms accounted for the highest rate, accounting for 94%. The rate of H.pylori infection in our study was 31.6%. Evaluation of gastritis through endoscopy: 146/177 congestive inflammation accounted for 79.3%, prominent sliding inflammation accounted for 15.8%, flat sliding inflammation accounted for 1.1%. Our study recorded that 181/184 patients with gastric and duodenal ulcers infected with H.pylori were treated with a 4-drug regimen containing bismuth, with success accounting for 98.4%.Conclusion: Patients with peptic ulcer disease infected with Helicobacter Pylori have the highest rate of abdominal pain, accounting for 94%. The rate of H.pylori infection in our study was 31.6%. Congestive inflammation 79.3%, floating sliding inflammation 15.8%, flat sliding inflammation 1.1%. Successful treatment to eliminate Helicobacter pylori accounts for 98.4%